US Stock MarketDetailed Quotes
ARCT Arcturus Therapeutics
- 27.175
- -0.755-2.70%
Trading Apr 24 11:10 ET
731.42MMarket Cap-24263P/E (TTM)
28.335High27.120Low56.57KVolume28.200Open27.930Pre Close1.58MTurnover0.23%Turnover RatioLossP/E (Static)26.92MShares43.81052wk High2.63P/B667.15MFloat Cap17.52052wk Low--Dividend TTM24.55MShs Float129.710Historical High--Div YieldTTM4.35%Amplitude4.110Historical Low27.870Avg Price1Lot Size
Arcturus Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -156.57%-18.1M | -100.39%-629K | 23.58%-32.41M | 237.98%50.81M | 26.85%-35.87M | 123.69%31.99M | 477.11%160.26M | -154.64%-42.41M | -11.77%-36.82M | -14.18%-49.04M |
| Net income from continuing operations | -417.95%-29.73M | -109.98%-11.71M | 54.00%-16.22M | -143.70%-52.55M | 199.19%50.75M | 104.59%9.35M | 403.51%117.35M | 34.79%-35.27M | 60.49%-21.56M | 9.19%-51.17M |
| Operating gains losses | -3,904.83%-33.86M | --0 | 95.53%-70K | --0 | -15,052.65%-33.79M | 181.50%890K | 568.86%3.35M | -511.72%-1.57M | -419.37%-1.12M | 113.39%226K |
| Depreciation and amortization | 93.65%2.96M | 47.91%815K | 98.32%827K | 120.00%737K | 158.04%578K | 28.00%1.53M | 77.74%551K | 44.29%417K | 16.72%335K | -27.04%224K |
| Other non cash items | -76.90%502K | --0 | --0 | --0 | -8.06%502K | -68.91%2.17M | -497.74%-2.91M | 347.65%4M | -39.57%536K | -90.41%546K |
| Change In working capital | 158.78%7.38M | -95.91%1.45M | -34.90%-26.21M | 522.93%94.24M | -895.57%-62.09M | -138.49%-12.56M | 403.11%35.39M | -165.56%-19.43M | -277.22%-22.28M | -397.85%-6.24M |
| -Change in receivables | -4,959.04%-29.3M | 955.00%6.16M | -17,548.77%-35.42M | 6,110.80%89.68M | -27,591.05%-89.72M | 148.55%603K | 46.75%-720K | 37.16%203K | 1,025.64%1.44M | -374.58%-324K |
| -Change in prepaid assets | 132.51%1.17M | 135.28%609K | -349.30%-4.16M | 106.79%163K | 210.30%4.55M | -53.62%-3.58M | -5,467.74%-1.73M | 66.61%-925K | -108.43%-2.4M | -9.45%1.47M |
| -Change in payables and accrued expense | -144.64%-2.83M | -870.17%-9.89M | -24.72%4.45M | -301.83%-10.16M | 455.13%12.77M | 88.14%6.33M | 86.65%-1.02M | 199.58%5.91M | -66.89%5.04M | -308.16%-3.6M |
| -Change in other current assets | 23.93%4.05M | 6.16%1.03M | 6.04%1.02M | 5.02%1M | 164.88%988K | 134.48%3.26M | --974K | --961K | --956K | --373K |
| -Change in other current liabilities | 3.75%-4.31M | -10.88%-1.11M | 68.55%-1.09M | -341.80%-1.08M | -131.24%-1.03M | -231.38%-4.48M | ---1M | ---3.48M | --445K | ---445K |
| -Change in other working capital | 362.73%38.61M | -88.05%4.65M | 140.68%8.99M | 152.68%14.63M | 378.79%10.34M | -144.81%-14.69M | 1,540.68%38.88M | -157.88%-22.1M | -1,990.66%-27.76M | -170.61%-3.71M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -156.57%-18.1M | -100.39%-629K | 23.58%-32.41M | 237.98%50.81M | 26.85%-35.87M | 123.69%31.99M | 477.11%160.26M | -154.64%-42.41M | -11.77%-36.82M | -14.18%-49.04M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 62.45%-2.9M | 77.02%-875K | 55.12%-981K | -193.65%-354K | 67.27%-691K | -126.83%-7.73M | -240.52%-3.81M | -23.78%-2.19M | 193.56%378K | -1,688.98%-2.11M |
| Net PPE purchase and sale | 62.45%-2.9M | 77.02%-875K | 55.12%-981K | -193.65%-354K | 67.27%-691K | -126.83%-7.73M | -240.52%-3.81M | -23.78%-2.19M | 193.56%378K | -1,688.98%-2.11M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 62.45%-2.9M | 77.02%-875K | 55.12%-981K | -193.65%-354K | 67.27%-691K | -126.83%-7.73M | -240.52%-3.81M | -23.78%-2.19M | 193.56%378K | -1,688.98%-2.11M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -742.50%-24.09M | -735.89%-18.66M | 1,890.16%21.84M | -63.42%94K | -8,244.05%-27.36M | -105.95%-2.86M | -1,070.43%-2.23M | -276.30%-1.22M | 213.41%257K | -99.29%336K |
| Net issuance payments of debt | -447.28%-27.36M | -566.67%-20M | 1,100.00%20M | --0 | ---27.36M | -110.73%-5M | ---3M | ---2M | --0 | --0 |
| Net common stock issuance | 48.18%609K | --0 | ---- | ---- | ---- | -20.19%411K | --0 | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | 54.22%2.67M | 74.87%1.34M | 233.60%1.23M | -63.42%94K | --0 | 91.80%1.73M | 233.91%768K | 108.47%369K | 213.41%257K | -18.64%336K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -742.50%-24.09M | -735.89%-18.66M | 1,890.16%21.84M | -63.42%94K | -8,244.05%-27.36M | -105.95%-2.86M | -1,070.43%-2.23M | -276.30%-1.22M | 213.41%257K | -99.29%336K |
| Net cash flow | ||||||||||
| Beginning cash position | 5.75%393.98M | 53.93%369.05M | 33.28%380.6M | 2.58%330.05M | 5.75%393.98M | -19.53%372.57M | -42.36%239.76M | -34.15%285.57M | -31.09%321.76M | -19.53%372.57M |
| Current changes in cash | -310.61%-45.09M | -113.07%-20.16M | 74.79%-11.55M | 239.69%50.55M | -25.80%-63.93M | 123.67%21.41M | 455.47%154.22M | -158.43%-45.81M | -8.78%-36.19M | -1,388.39%-50.81M |
| End cash Position | -11.44%348.89M | -11.44%348.89M | 53.93%369.05M | 33.28%380.6M | 2.58%330.05M | 5.75%393.98M | 5.75%393.98M | -42.36%239.76M | -34.15%285.57M | -31.09%321.76M |
| Free cash flow | -186.54%-21M | -100.96%-1.5M | 25.13%-33.39M | 238.44%50.45M | 28.52%-36.56M | 117.53%24.27M | 458.71%156.45M | -142.10%-44.59M | -9.28%-36.44M | -18.77%-51.15M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg